As­traZeneca and Glax­o­SmithK­line come to a peace­ful set­tle­ment of their tug of war over Luke Miels

It looks like Luke Miels “gar­den­ing leave” will run through the sum­mer be­fore he bids one fi­nal farewell to As­traZeneca and moves over to Glax­o­SmithK­line …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA